In a study from 2019, it was observed that high doses of berberine reduced the expression of TGF-β1, Smad2, and Smad3 in the cigarette smoke extract (CSE)-induced COPD mice model. Here, SMAD2 is linked to chronic obstructive pulmonary disease.